Duurzame responsen tisagenlecleucel bij recidiverend/refractair DLBCL

Delen via:
ASH 2018

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Schuster SJ, Bishop MR, Tam C, et al. Sustained disease control for adult patients with relapsed or refractory diffuse large B-cell lymphoma: an updated analysis of Juliet, a global pivotal phase 2 trial of tisagenlecleucel. ASH Annual Meeting and Exposition 2018, abstract 1684.